The use of melatonin for treating sleep disorders in patients with Parkinson’s disease
Most patients with Parkinson’s disease (PD) experience sleep-related problems, such as difficulty in initiating and maintaining sleep, excessive daytime sleepiness, sleep fragmentation, reductions in non-rapid eye movement (NREM) or rapid eye movement (REM) sleep, and REM sleep behavior disorder. A...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/44666/1/f_CPT%20the-use-of-melatonin-for-treating-sleep-disorders.pdf |
| _version_ | 1797011228871098368 |
|---|---|
| author | Srinivasan, Venkataramanujam Berardis, Domenico De Partonen, Timo Zakaria, Rahimah Othman, Zahiruddin |
| author_facet | Srinivasan, Venkataramanujam Berardis, Domenico De Partonen, Timo Zakaria, Rahimah Othman, Zahiruddin |
| author_sort | Srinivasan, Venkataramanujam |
| collection | USM |
| description | Most patients with Parkinson’s disease (PD) experience sleep-related problems, such as difficulty in initiating and maintaining sleep, excessive daytime sleepiness, sleep fragmentation,
reductions in non-rapid eye movement (NREM) or rapid eye movement (REM) sleep, and REM sleep behavior disorder. Although motor symptoms of PD are treated with dopaminergic drugs, the nonmotor symptoms pose a big problem, and they often precede the onset of the disease. Treating the nonmotor symptoms, such as sleep and associated behavioral disorders, is beneficial, for it not only relieves the symptoms but also helps to slow the progression of the disease. Treating PD patients with melatonin has been shown to be beneficial in treating sleep and behavior problems. The finding of reduced expression of the MT1 and MT2 melatonin receptors
in amygdalae and substantia nigra of PD patients supports the involvement of melatonergic system in the etiology of PD. Hence, the use of melatonin or its analogs may even be beneficial not only for improving sleep quality but also for enhancing neuroprotection in PD. |
| first_indexed | 2024-03-06T15:31:17Z |
| format | Article |
| id | usm.eprints-44666 |
| institution | Universiti Sains Malaysia |
| language | English |
| last_indexed | 2024-03-06T15:31:17Z |
| publishDate | 2014 |
| publisher | Dove Medical Press |
| record_format | dspace |
| spelling | usm.eprints-446662019-06-19T03:17:32Z http://eprints.usm.my/44666/ The use of melatonin for treating sleep disorders in patients with Parkinson’s disease Srinivasan, Venkataramanujam Berardis, Domenico De Partonen, Timo Zakaria, Rahimah Othman, Zahiruddin RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry Most patients with Parkinson’s disease (PD) experience sleep-related problems, such as difficulty in initiating and maintaining sleep, excessive daytime sleepiness, sleep fragmentation, reductions in non-rapid eye movement (NREM) or rapid eye movement (REM) sleep, and REM sleep behavior disorder. Although motor symptoms of PD are treated with dopaminergic drugs, the nonmotor symptoms pose a big problem, and they often precede the onset of the disease. Treating the nonmotor symptoms, such as sleep and associated behavioral disorders, is beneficial, for it not only relieves the symptoms but also helps to slow the progression of the disease. Treating PD patients with melatonin has been shown to be beneficial in treating sleep and behavior problems. The finding of reduced expression of the MT1 and MT2 melatonin receptors in amygdalae and substantia nigra of PD patients supports the involvement of melatonergic system in the etiology of PD. Hence, the use of melatonin or its analogs may even be beneficial not only for improving sleep quality but also for enhancing neuroprotection in PD. Dove Medical Press 2014 Article PeerReviewed application/pdf en http://eprints.usm.my/44666/1/f_CPT%20the-use-of-melatonin-for-treating-sleep-disorders.pdf Srinivasan, Venkataramanujam and Berardis, Domenico De and Partonen, Timo and Zakaria, Rahimah and Othman, Zahiruddin (2014) The use of melatonin for treating sleep disorders in patients with Parkinson’s disease. ChronoPhysiology and Therapy, 4. pp. 51-57. ISSN 2230-2026 https://doi.org/10.2147/CPT.S44802 |
| spellingShingle | RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry Srinivasan, Venkataramanujam Berardis, Domenico De Partonen, Timo Zakaria, Rahimah Othman, Zahiruddin The use of melatonin for treating sleep disorders in patients with Parkinson’s disease |
| title | The use of melatonin for treating sleep disorders in patients with Parkinson’s disease |
| title_full | The use of melatonin for treating sleep disorders in patients with Parkinson’s disease |
| title_fullStr | The use of melatonin for treating sleep disorders in patients with Parkinson’s disease |
| title_full_unstemmed | The use of melatonin for treating sleep disorders in patients with Parkinson’s disease |
| title_short | The use of melatonin for treating sleep disorders in patients with Parkinson’s disease |
| title_sort | use of melatonin for treating sleep disorders in patients with parkinson s disease |
| topic | RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry |
| url | http://eprints.usm.my/44666/1/f_CPT%20the-use-of-melatonin-for-treating-sleep-disorders.pdf |
| work_keys_str_mv | AT srinivasanvenkataramanujam theuseofmelatoninfortreatingsleepdisordersinpatientswithparkinsonsdisease AT berardisdomenicode theuseofmelatoninfortreatingsleepdisordersinpatientswithparkinsonsdisease AT partonentimo theuseofmelatoninfortreatingsleepdisordersinpatientswithparkinsonsdisease AT zakariarahimah theuseofmelatoninfortreatingsleepdisordersinpatientswithparkinsonsdisease AT othmanzahiruddin theuseofmelatoninfortreatingsleepdisordersinpatientswithparkinsonsdisease AT srinivasanvenkataramanujam useofmelatoninfortreatingsleepdisordersinpatientswithparkinsonsdisease AT berardisdomenicode useofmelatoninfortreatingsleepdisordersinpatientswithparkinsonsdisease AT partonentimo useofmelatoninfortreatingsleepdisordersinpatientswithparkinsonsdisease AT zakariarahimah useofmelatoninfortreatingsleepdisordersinpatientswithparkinsonsdisease AT othmanzahiruddin useofmelatoninfortreatingsleepdisordersinpatientswithparkinsonsdisease |